Clinical Trial Update: Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

View source ↗

Summary

A completed clinical trial examining outcomes of hepatitis C after living donor liver transplantation in relation to IL28B genotype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Henry Ford Health System | Conditions: Hepatitis C | Status: COMPLETED